Lyons Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-12,202
Closed -$764K 48
2016
Q4
$764K Buy
12,202
+179
+1% +$10.9K 1.04% 28
2016
Q3
$760K Buy
+12,023
New +$778K 1.05% 29
2015
Q1
Sell
-17,271
Closed -$1.13M 62
2014
Q4
$1.13M Sell
17,271
-720
-4% -$45.4K 1.19% 19
2014
Q3
$1.04M Buy
17,991
+377
+2% +$20.9K 1.11% 22
2014
Q2
$995K Buy
17,614
+3,277
+23% +$172K 0.89% 26
2014
Q1
$734K Buy
14,337
+3,221
+29% +$163K 0.64% 31
2013
Q4
$589K Buy
11,116
+1,188
+12% +$58.4K 0.55% 23
2013
Q3
$444K Buy
+9,928
New +$440K 0.4% 23

Other funds holding ABBV

Lyons Wealth Management's ABBV Position: Q1 2017 in Review

Lyons Wealth Management sold out of AbbVie (ABBV) in Q1 2017, closing a stake of 12,202 shares — an estimated $764K sold.

Lyons Wealth Management first reported a position in ABBV in Q3 2013 and held it in 8 quarters. The position peaked at $1.13M in Q4 2014. 1,727 funds tracked by Wall St. Rank hold ABBV as of Q1 2017.

  • Lyons Wealth Management reported no remaining AbbVie position as of Q1 2017 after selling out during the quarter.
  • Lyons Wealth Management sold 12,202 AbbVie shares in Q1 2017, an estimated $764K.
  • Lyons Wealth Management first reported a position in AbbVie in Q3 2013 and held it in 8 quarters.
  • Lyons Wealth Management's AbbVie position peaked at $1.13M in Q4 2014.
  • 1,727 funds tracked by Wall St. Rank held AbbVie as of Q1 2017.

Based on Lyons Wealth Management's 13F filing for Q1 2017, filed 15 May 2017.